Eurofarma Laboratorios S.a.

This study aimed to see if a single pill combining two diabetes medications works better than taking them separately for people with type 2 diabetes already on metformin. The goal was to improve blood sugar control and reduce side effects like weight gain and swelling. However, t…

This study aimed to see if a new lower-dose asthma inhaler (formoterol 6 mcg/fluticasone 125 mcg) works as well as an existing one (formoterol 6 mcg/budesonide 200 mcg) for people aged 12 and older with moderate asthma. The trial was withdrawn before any participants were enrolle…

This was a planned phase 3 study to test a new combination of two drugs, sibutramine and topiramate, for weight loss in overweight and obese adults. The study aimed to see if the combination worked better than either drug alone or a placebo. However, the trial was withdrawn befor…

This study planned to test whether adding two newer diabetes drugs (Forxiga and Januvia) to standard metformin treatment could better control blood sugar in people with type 2 diabetes. It aimed to enroll adults aged 18–80 whose diabetes was not well controlled on metformin alone…

This study was designed to see if a combination of levocetirizine (an allergy medicine) and pseudoephedrine (a decongestant) works better than levocetirizine alone for relieving nasal congestion in people with allergic rhinitis. It planned to enroll people aged 12 to 65 with the …

This study was designed to test a new drug called N0750 against two standard pain medications (Cymbalta and Lyrica) for painful diabetic peripheral neuropathy. It planned to enroll adults with diabetes and nerve pain for at least 3 months. However, the trial was withdrawn before …